Skip to main content

Table 2 Laboratory and imaging results for two patients with infantile-onset lysosomal acid lipase deficiency treated with enzyme replacement therapy (ERT)

From: Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy

 

Laboratory/imaging results in relation to ERT

Albumin (g/dl) (normal range for age)/SI units (g/L)

AST (U/L) (normal range for age)/SI units (μkat/L)

ALT (U/L) (normal range for age)/SI units (μkat/L)

GGTP (IU/L) (normal range for age)/SI units (μkat/L)

Ferritin (ng/ml) (normal range for age)/SI units (pmol/L)

PT (secs) (normal range)

PTT (secs) (normal range)

INR

Total cholesterol (mg/dL) (normal range for age)/SI units (mmol/L)

TG (mg/dL) (normal range for age)/SI units (mmol/L)

LDL (mg/dL) (normal range for age)/SI units (mmol/L)

HDL (mg/dL) (normal range for age)/SI units (mmol/L)

Liver size (cm)

Spleen volume (ml)

Patient #1

prior to ERT

4.4 (3.1–4.2)/44

141 (20–64)/2.35

59 (12–42)/0.99

22/0.37

45.1 (10–112)/101.34

13.5 (11.6–13.8)

28.3 (22–36)

1.08

173 (45–182)/4.48

190 (27–125)/2.15

117 (63–129)/3.03

18 (35–82)/0.47

11.9b

35b

after 3 months ERT

4.4 (3.3–4.3)/44

107 (20–64)/1.79

36 (12–42)/0.60

 

26.5 (10–112)/59.55

13.5 (11.6–13.8)

29.2 (22–36)

1.08

185 (45–182)/4.79

95 (27–125)/1.07

141 (63–129)/3.65

25 (35–82)/0.65

  

after 12 months ERT

3.6 (3.5–4.6)/36

81 (20–60)/1.35

48 (5–45)/0.80

 

19.4 (10–70)/43.59

13.9 (11.6–13.8)

 

1.11

238 (45–182)/6.16

129 (27–125)/1.46

191 (63–129)/4.95

21 (35–82)/0.54

12.4b

43b

after 18 months ERT

3.8 (3.5–4.6)/38

91 (20–60)/1.52

56 (5–45)/0.94

 

15.5 (10–70)/34.83

11.8 (10.9–13.4)

30.1a (22–36)

0.97

141a (45–182)/3.65

221a (27–125)/2.50

86a (63–129)/2.23

11a (35–82)/0.28

  

after 22 months ERT

4.0 (3.5–4.6)/40

58 (20–60)/0.97

40 (5–45)/0.67

 

13.5 (10–99.9)/30.33

   

128 (45–182)/3.32

99 (27–125)/1.12

89 (63–129)/2.31

19 (35–82)/0.49

  

Patient #2

prior to ERT

2.5 (3.4–4.2)/25

189 (0–120)/3.16

62 (0–28)/1.04

453 (6–19)/7.57

7640 (9–120)/17,167.08

13.6

25.2

1.04

224 (0–200)/5.80

593 (60–160)/6.70

TG result too high for accurate LDL estimation; LDL direct: 95 (0–159)/2.46

34 (35–150)/0.88

10c

157c

after 3 months ERT

3.7 (3.4–4.2)/37

61 (20–60)/1.02

54 (5–45)/0.90

290 (6–19)/4.84

39.90 (9–120)/89.66

14.4

33.9

1.11

167 (0–200)/4.33

114 (60–160)/1.29

126 (0–129)/3.26

18 (35–150)/0.47

  

after 12 months ERT

3.9 (3.4–4.2)/39

55 (20–60)/0.92

58 (5–45)/0.97

97 (6–19)/1.62

21.8 (9–120)/48.98

14.4 (12.2–14.4)

27.1

1.11

191 (0–200)/4.95

159 (60–160)/1.80

139 (0–129)/3.60

20 (35–150)/0.52

8.6c

127c

  1. AST Aspartate aminotransferase, ALT Alanine aminotransferase, GGTP Gamma glutamyl transpeptidase, PT Prothrombin time, PTT Partial thromboplastin time, TG Triglycerides, LDL Low-density lipoprotein, HDL High-density lipoprotein,aAfter 15 months of ERT, bbased on MRI, cbased on ultrasound